Bruno Julianne (CIK 2019645) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-12). Recent activity: Buy GLTO (129,000 shares), Buy CRSP (3,750 shares), Sell CRSP (1,714 shares), Buy CRSP (2,399 shares), Sell CRSP (1,198 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-12 | Galecto, Inc. (GLTO) | Director | Buy | 129,000 | $0 |
| 2025-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Operating Officer | Buy | 3,750 | $0 |
| 2025-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Operating Officer | Sell | 1,714 | $70,668 |
| 2025-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Operating Officer | Buy | 2,399 | $0 |
| 2025-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Operating Officer | Sell | 1,198 | $50,819 |
| 2025-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Operating Officer | Buy | 435 | $0 |
| 2025-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Operating Officer | Sell | 190 | $8,231 |
| 2025-02-19 | CRISPR Therapeutics AG (CRSP) | Chief Operating Officer | Buy | 650 | $0 |
| 2025-02-19 | CRISPR Therapeutics AG (CRSP) | Chief Operating Officer | Sell | 333 | $17,582 |
Source: SEC Form 4 filings · as of 2026-02-12